We report the first detection of bla in South America, 
Worldwide dissemination of CTX-M-derived extended spectrum b-lactamases (ESBLs) is a well-known concern [1] . Although this process probably began simultaneously at the beginning of the 1990s in Europe and South America [2] , differences in antibiotic pressure forces resulted in different evolutionary routes. Thus, while CTX-M-9, CTX-M-14 and CTX-M-15 were frequently detected in Europe [1] , CTX-M-2 was predominant in many countries of South America [3] [4] [5] .
Nevertheless, this situation has been gradually changing, and the arrival of CTX-M-2 in Europe [1] was accompanied by the progressive detection of CTX-M-9, CTX-M-14 and CTX-M-15 in our continent [3] [4] [5] [6] [7] . However, so far, the ceftazidimase CTX-M-19 has only been reported in Europe [8] .
In December 2010, Escherichia coli strain EC1737 was isolated from a urine sample from a 10-year-old girl admitted to the paediatric hospital Centro Hospitalario Pereira Rossell (CHPR) of Montevideo, Uruguay.
Identification and antibiotic susceptibility profile were determined using the VITEK â 2 Compact system (bioM erieux, Marcy l'Etoile, France). Minimal inhibitory concentration values for ciprofloxacin, cefotaxime, ceftazidime, gentamicin, and amikacin were determined by E-test; results were interpreted according to EUCAST guidelines (http://www.eucast.org). Strain EC1737 displayed a ceftazidimase-like profile, being resistant to gentamicin, nalidixic acid, ciprofloxacin, nitrofurantoin and trimethoprim-sulfamethoxazole; nevertheless, EC1737 remained susceptible to amikacin, imipenem and meropenem ( Table 1) .
The genes bla CTX-M , bla SHV , bla TEM and bla PER-2 were sought by polymerase chain reaction (PCR) and sequencing [5] [6] [7] , confirming the presence of bla CTX-M-19 and bla TEM-1 , respectively.
In order to identify other mechanisms responsible for the observed resistance profile, we used PCR and sequencing to study the presence of (a) class-1 and 2 integrons [5, 9] , (b) sul1, 2 and 3 genes, (c) plasmid-mediated quinolone-resistance genes (qnrABCDS, aac(6′)Ib-cr and qepA), and (d) mutations in the quinolone-resistance determining region (QRDR) [10] .
In this sense, strain EC1737 harboured sul1 and sul2 genes and a class-1 integron with a 1500 bp variable region featuring a dfr17-aadA5 array. These genes usually determine resistance to trimethoprim-sulfamethoxazole, streptomycin and spectinomycin.
No plasmid-mediated quinolone resistance genes were detected. Nevertheless, the analysis of the QRDR showed two modifications in gyrA (Ser83Leu and Asp87Asn) and one in parC (Glu84Lys), compared to wild-type alleles in E. coli K-12 (GenBank accession NP_416734 and NP_417491, respectively). These mutations have previously been highlighted as responsible for resistance to ciprofloxacin [11, 12] .
The probable association of bla CTX-M-19 to insertion sequences such as ISEcp1, IS26, IS903, ISCR1 was sought by PCR and sequencing [6] . In this regard, bla CTX-M-19 was flanked by IS26 and IS903 (upstream and downstream, respectively). IS26 and bla CTX-M-19 were separated by an 819 bp segment; interestingly, this segment was formed by 544 bp corresponding to a truncated IS10 insertion sequence and another 275 bp belonging to a fragment of ISEcp1, a genetic element commonly found upstream from bla CTX-M-14 alleles [13] (Fig. 1) .
Conjugation assays were carried out using E. coli J53-2 (rifampin resistant, non-motile and ornithine negative) as recipient; transconjugants were selected on MacConkey agar supplemented with rifampin (150 mg/L) and ceftriaxone (1 mg/ L), or gentamicin (4 mg/L) [6] .
Two different sets of transconjugants were obtained ( Fig. 2) : (a) ceftriaxone-selected transconjugants (TcEC1737-CRO), displaying only a similar b-lactam resistance pattern as the donor strain, and positive PCR results for bla CTX-M (Table 1) ; and (b) gentamicin-selected transconjugants (TcEC1737CN), showing resistance to b-lactams, aminoglycosides, and trimethoprim-sulfamethoxazole, but remaining susceptible to nitrofurantoin and quinolones. PCR results were positive for bla CTX-M , bla TEM , intI1, qacEdelta-1, sul1 and sul2, and confirmed the transfer of a class-1 integron with a 1500 bp variable region.
The plasmid incompatibility group was determined by PCR according to Carattoli et al. [14] .
IncI1, IncF, IncFIA and IncFIB, were detected in EC1737 and TcEC1737CN but only IncI1 and IncF were detected in TcEC1737CRO.
Plasmid size was estimated, for the donor strain and transconjugants, by treatment with S1 nuclease (Fermentas, Life Sciences, Vilnius, Lithuania) followed by pulsed-field gel electrophoresis (PFGE) as described previously [15] .
Both strain EC1737 and TcEC1737CN harboured two plasmids of 100 kb and 110 kb, approximately, whereas TcEC1737CRO only harboured a 100 kb plasmid (Fig. 2) .
The presence of plasmid maintenance mechanisms (i.e. addiction systems) in the donor strain and transconjugants TcEC1737CRO and TcEC1737CN was sought by PCR, as reported elsewhere [16] . Results were confirmed by amplicon sequencing.
EC1737 and TcEC1737CN showed the presence of pndAC, vagCD, ccdAB, hok/sok and pemKI, whereas TcEC1737CRO only showed the presence of pndAC and hok/sok systems. 
Values in parentheses were determined by the Vitek-2 system. Genetic characterization of strain EC1737 was done by: (a) determination of the phylogenetic group, according to Clermont et al. [17] ; (b) screening for virulence determinants, according Johnson et al. [18] ; and (c) multiple locus sequence typing (MLST), following the guidelines described in http://mlst. ucc.ie/mlst/dbs/Ecoli.
In this sense, EC1737 belongs to phylogenetic group A; screening for pathogenicity genes only yielded positive results for iutA, whereas MLST assay showed that this strain belongs to sequence type 603 (ST603; allelic profile, 6, 4, 4, 16, 43, 8, 6) .
The occurrence of human isolates harbouring bla CTX-M-19 has been reported only once, namely from a faecal isolate of Klebsiella pneumoniae from a hospitalized girl in France, co-colonized by E. coli and K. pneumoniae harbouring CTX-M-14 (a likely precursor of CTX-M-19) [8] .
Although there is no description of the plasmid bearing the bla CTX-M-19 allele, such a gene was found to be flanked by two full insertion sequences, namely ISEcp1B and IS903D [13] .
Interestingly, Ho et al. [19] and Kim et al. [20] have described alternative surroundings for bla CTX-M-14 , involving the interruption of ISEcp1 by the insertion in different sites of IS10 or IS26.
Contrary to previous reports regarding CTX-M-9-derived genes, bla CTX-M-19 in pEC1737 was preceded by three tandem-like transposons, which appear to have inserted one inside the other; this reflects the plasticity of insertion sequences to mobilize antibiotic resistance genes. Regardless of the different events of insertion and deletion of the various insertion sequences, the expression of bla CTX-M-19 seems to be driven by the promoter sequence present in ISEcp1, previously described by Poirel et al. [13] .
Although E. coli EC1737 is not an ExPEC strain, this type of microorganism could act as a reservoir or carrier of antibiotic resistance genes, as suggested by the presence in this strain of two transferable plasmids. Additionally, the presence of at least two insertion sequences flanking bla CTX-M-19 could account for self-transfer events between different plasmids, or even from plasmids to the bacterial chromosome.
The sequence of bla CTX-M-19 and its surrounding region was deposited in the EMBL database (European Bioinformatics Institute) under accession number HG000669.
